None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy male and female subjects aged 18-65 years Willing to participate in the study and sign the informed consent form
Exclusion criteria
Exclusion criteria: Subject allergic to egg, fish oil or omega-3 supplements. Subject consuming omega-3 supplements or having used Omega 3 supplements in 6 months preceding the intervention period. Subjects with uncontrolled hypertension (SBP >=160 mm Hg or DBP >=100 mmHg), coronary artery disease, uncontrolled diabetes, renal impairment, cerebrovascular and peripheral artery disease which under the opinion of the investigator would influence the conduct or outcome of the study. Subjects with history of alcohol abuse, other sedatives or drugs. Subjects participated in another clinical study in the past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Omega -3 fatty acid level in blood plasma at Day 15 and Day 30 compared to baselineTimepoint: Baseline, Day 15, Day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Lipid profile, Serum calcium, Urine calcium at Day 15 and Day 30 compared to baseline Timepoint: Baseline, Day 15, Day 30 | — |
Countries
India
Contacts
Arjuna Natural Private Limited